Immediate Impact

35 standout
Sub-graph 1 of 14

Citing Papers

Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
3 intermediate papers

Works of Aileen Cohen being referenced

PB1890: ZANUBRUTINIB IN ACALABRUTINIB-INTOLERANT PATIENTS (PTS) WITH B-CELL MALIGNANCIES
2022
ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
2020

Author Peers

Author Last Decade Papers Cites
Aileen Cohen 257 234 122 30 348
Max J. Gordon 160 194 58 41 334
Arif Alam 112 161 122 26 327
Anna Schmitt 211 169 95 20 305
Julia von Tresckow 328 299 89 31 384
Sotirios Sachanas 153 206 103 31 369
Eric J. Avery 329 266 115 16 393
Gerasimos Pangalis 223 177 105 21 363
Lidija Čevreska 160 144 142 39 385
Juan Besalduch 114 178 147 23 332
Vít Campr 112 197 78 45 312

All Works

Loading papers...

Rankless by CCL
2026